Advancing Science on Age-Related Macular Degeneration

1.50 CME
0 MINS
$0 FEE
SAVE
You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Provider Statement: This continuing medical education activity is provided by Vindico Medical Education.

Support Statement: This activity is supported by an educational grant from Genentech, Inc.

Target Audience: The intended audience for this activity is ophthalmologists and other health care professionals involved in the treatment of patients with AMD.

Learning Objectives: Upon successful completion of this activity, participants should be better able to:

  • Assess the increasing prevalence of early to advanced age-related macular degeneration (AMD), as well as its pathophysiology to better understand the visual impairment caused by the condition.
  • Employ classification criteria, imaging, and other measures of visual function to improve the early diagnosis of AMD, as well as better define its stages.
  • Describe new therapeutic targets and mechanisms of action of therapies currently in late stages of development for exudative and non-exudative AMD.
  • Apply safety and efficacy data when assessing therapies currently used or under investigation for exudative and non-exudative AMD.

Activity Chair:
Rishi P. Singh, MD
Staff Physician, Cole Eye Institute 
Medical Director, Clinical Systems Office 
Cleveland Clinic 
Associate Professor of Ophthalmology 
Case Western Reserve University 
Cleveland, OH

Faculty:
David S. Boyer, MD
Clinical Professor of Ophthalmology 
University of Southern California-Keck School of Medicine 
Senior Partner, Retina-Vitreous Associates Medical Group 
Los Angeles, CA

Frank G. Holz, MD, FEBO
Professor and Chairman 
Department of Ophthalmology 
University of Bonn 
Bonn, Germany

SriniVas R. Sadda, MD
President and Chief Scientific Officer 
Stephen J. Ryan Endowed Chair 
Doheny Eye Institute 
Professor of Ophthalmology, UCLA 
Los Angeles, CA

Reviewer:
Ronald A. Codario, MD, FACP, FNLA, RPVI, CHCP

Accreditation:
Vindico Medical Education is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Credit Designation:
Vindico Medical Education designates this enduring material for a maximum of 1.5 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

This enduring material is approved for 1 year from the date of original release, January 25, 2018 through January 24, 2019.

How to Participate in this Activity and Obtain CME Credit:
To participate in this CME activity, you must read the objectives, answer the pretest questions, review the articles, and complete the posttest and evaluation. Provide only one (1) correct answer for each question. A satisfactory score is defined as answering 3 out of 4 of the posttest questions correctly. Upon receipt of the completed materials, if a satisfactory score on the posttest is achieved, Vindico Medical Education will issue an AMA PRA Category 1 Credit(s)™ Certificate.

Disclosures:
In accordance with the Accreditation Council for Continuing Medical Education’s Standards for Commercial Support, all CME providers are required to disclose to the activity audience the relevant financial relationships of the planners, teachers, and authors involved in the development of CME content. An individual has a relevant financial relationship if he or she has a financial relationship in any amount occurring in the last 12 months with a commercial interest whose products or services are discussed in the CME activity content over which the individual has control.

The authors disclose that they do have significant financial interests in any products or class of products discussed directly or indirectly in this activity, including research support.

Faculty and planning committee members report the following relationship(s):
David S. Boyer, MD
Consulting Fee: Allergan, Apellis, OptoVue, Roche
Speakers Bureau: Allergan
Contracted Research: Allergan

Frank G. Holz, MD, FEBO
Consulting Fee: Bayer, Boehringer Ingelheim, Centervue, Fermycon, Genentech/Roche, Novartis, Thea
Speakers Bureau: Bayer, Boehringer Ingelheim, Centervue, Fermycon, Genentech/Roche, Heidelberg Engineering, Novartis, Thea
Contracted Research: Bayer, Centervue, Fermycon, Genentech/Roche, Novartis

SriniVas R. Sadda, MD
Consulting Fee: Allergan, Centervue, Genentech, Heidelberg, Iconic, Novartis, Optos, ThromboGenics
Contracted Research: Allergan, Carl Zeiss Meditec, Genentech, Optos

Rishi P. Singh, MD
Consulting Fee: Alcon, Allergan, Genentech, Optos, Regeneron, Shire, Zeiss
Contracted Research: Alcon, Apellis, Genentech, Regeneron

Reviewer reports the following relationship(s):
Ronald A. Codario, MD, FACP, FNLA, RPVI, CHCP
No relevant financial relationships to disclose.

Vindico Medical Education staff report the following relationship(s):
No relevant financial relationships to disclose.

Signed disclosures are on file at Vindico Medical Education, Office of Medical Affairs and Compliance.

Unlabeled and Investigational Usage:
The audience is advised that this continuing medical education activity may contain references to unlabeled uses of FDA-approved products or to products not approved by the FDA for use in the United States. The faculty members have been made aware of their obligation to disclose such usage. All activity participants will be informed if any speakers/authors intend to discuss either non-FDA approved or investigational use of products/devices.

Copyright Statement:
Created and published by Vindico Medical Education, 6900 Grove Road, Building 100, Thorofare, NJ 08086-9447. Telephone: 856-994-9400; Fax: 856-384-6680. Printed in the USA. Copyright © 2018 Vindico Medical Education. All rights reserved. No part of this publication may be reproduced without written permission from the publisher. The material presented at or in any of Vindico Medical Education continuing medical education activities does not necessarily reflect the views and opinions of Vindico Medical Education. Neither Vindico Medical Education nor the faculty endorse or recommend any techniques, commercial products, or manufacturers. The faculty/authors may discuss the use of materials and/or products that have not yet been approved by the US Food and Drug Administration. All readers and continuing education participants should verify all information before treating patients or utilizing any product.

CME Questions?
Contact us at cme@vindicoCME.com